Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Provider-Mediated Communication of Genetic Testing Results to At-Risk Relatives of Cancer Patients to Improve Genetic Counseling and Testing Rates, Family HOPE Study

City of Hope Medical Center · with National Cancer Institute (NCI) · NCT05772130

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
240
US sites recruiting
1
Study start
March 10, 2023
Record last updated
October 16, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This clinical trial tests whether provider-mediated communication of genetic testing results to at-risk relatives of cancer patients can help improve genetic counseling and testing rates. Approximately 15% of people with cancer have an inherited form of cancer due to changes in a gene that they have inherited from one of their parents. These changes increase a person's risk for developing cancer. Most people who have an inherited harmful change in a cancer risk gene don't know that they have it and are therefore not able to get the health care that they need. The primary reason for this problem has been a lack of genetic counseling and testing for cancer patients and patients with a strong family history of cancer. Another reason for this lack of awareness is that, when cancer runs in a family, the patient who carries the gene change usually has to communicate the genetic risk information to their family members. When this process doesn't work well, family members may not know that they need to get genetic testing and then may not get potentially life-saving care. Provider-mediated contact to discuss genetic test results may help improve rates of genetic testing among at-risk relatives of patients with a family cancer syndrome.

Being studied: Best Practice; Electronic Health Record Review; Personal Contact; Survey Administration

Conditions: Hematopoietic and Lymphoid System Neoplasm; Hereditary Malignant Neoplasm; Malignant Solid Neoplasm

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • PATIENTS: Enrolled in City of Hope (COH) institutional review board (IRB) 07047 or have been seen by COH Genetics for genetic testing
  • PATIENTS: Have an pathogenic/ likely pathogenic germline variant
  • PATIENTS: Fluent in English
  • PATIENTS: Age >= 18 years
  • PATIENTS: Willing to provide contact information for eligible first-degree relatives
  • PATIENTS: >= 2 first-degree relatives that are eligible for genetic testing and reside in the United States of America
  • FIRST-DEGREE RELATIVES: Proband is a COH patient and has consented to this study
  • FIRST-DEGREE RELATIVES: First-degree relative of proband
  • FIRST-DEGREE RELATIVES: Resides within the United States
  • FIRST-DEGREE RELATIVES: Has not undergone genetic testing for the known familial variant
  • FIRST-DEGREE RELATIVES: Are fluent in English
  • FIRST-DEGREE RELATIVES: Age >= 18 years

Exclusion Criteria

  • PATIENTS: Unable to provide informed consent
  • PATIENTS: =\< 2 at-risk first-degree relatives who are eligible for genetic testing and/or reside within the United States
  • PATIENTS: Unwilling to provide contact information for family members
  • FIRST-DEGREE RELATIVES: Unable or unwilling to provide informed consent
  • FIRST-DEGREE RELATIVES: Have undergone genetic testing for the known familial variant
  • FIRST-DEGREE RELATIVES: Resides outside of the United States

Recruiting US locations

  • City of Hope Medical Center

    Duarte, CA 91010

    Site contact: Stacy W. Gray · 626-218-8662 · stagray@coh.org

Provider-Mediated Communication of Genetic Testing Results to… (NCT05772130) | Bored Studies